Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease”

3,949 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,949 results

Large-scale testing (Phase 3)Ended earlyNCT00865579
What this trial is testing

Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 964
Not applicableStudy completedNCT03531086
What this trial is testing

Idiopathic Parkinson's Progression and Dopamine Transporter SPECT

Who this might be right for
Parkinson Disease
Julie Gurwell 12
Not applicableUnknownNCT06430151
What this trial is testing

Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease

Who this might be right for
Parkinson Disease
Dr Alistair Mackett 20
Not applicableStudy completedNCT06389903
What this trial is testing

Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease

Who this might be right for
Parkinson Disease
Centre Hospitalier du Rouvray 15
Not applicableStudy completedNCT02236286
What this trial is testing

Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact

Who this might be right for
Parkinson's Disease
Oregon Health and Science University 16
Testing effectiveness (Phase 2)Study completedNCT06329141
What this trial is testing

Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Glaceum 99
Early research (Phase 1)Study completedNCT03562494
What this trial is testing

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Who this might be right for
Parkinson's Disease
Neurocrine Biosciences 14
Testing effectiveness (Phase 2)Ended earlyNCT03306329
What this trial is testing

DNS-7801 vs. Placebo in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Dart NeuroScience, LLC 5
Not applicableStudy completedNCT03232996
What this trial is testing

Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease.

Who this might be right for
Parkinson DiseaseParkinson
University of Manitoba 30
Large-scale testing (Phase 3)Ended earlyNCT01215227
What this trial is testing

An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
Merck Sharp & Dohme LLC 839
Testing effectiveness (Phase 2)Active Not RecruitingNCT04491383
What this trial is testing

Tocotrienols in Parkinson's Disease (PD)

Who this might be right for
Neuro-Degenerative DiseaseParkinson Disease
National Neuroscience Institute 100
Not applicableEnded earlyNCT03922672
What this trial is testing

Piano Training, Caregivers, and Parkinson's Disease

Who this might be right for
DepressionMoodBurden, Dependency
University of Miami 14
Not applicableUnknownNCT06104072
What this trial is testing

Effect of Adding Computerized Cognitive Training on Balance, Locomotion and Cognition in Parkinson's Disease

Who this might be right for
Parkinson Disease
Engy Badreldin Saleh Moustafa, PhD 70
Post-approval studies (Phase 4)UnknownNCT05855577
What this trial is testing

Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients

Who this might be right for
Parkinson DiseaseGait AnalysisTherapy, Directly Observed+1 more
I.R.C.C.S. Fondazione Santa Lucia 50
Large-scale testing (Phase 3)Study completedNCT02091739
What this trial is testing

Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions

Who this might be right for
Chronic Troublesome SialorrheaParkinson's DiseasePost-stroke+1 more
Merz Pharmaceuticals GmbH 184
Not applicableActive Not RecruitingNCT04507139
What this trial is testing

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Who this might be right for
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research 50
Not applicableUnknownNCT00888095
What this trial is testing

Deep Brain Stimulation (DBS) For Parkinson's Disease: Caudal Zona Incerta Versus Subthalamic Nucleus

Who this might be right for
Parkinson's Disease
Charite University, Berlin, Germany 70
Not applicableStudy completedNCT04273672
What this trial is testing

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

Who this might be right for
Parkinson DiseaseCognitive Impairment, MildSpeech
University of Massachusetts, Worcester 58
Testing effectiveness (Phase 2)Study completedNCT01275573
What this trial is testing

Evaluation of the Effect of Repetitive Transcranial Magnetic Stimulation in Pain Perception in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Hospital, Toulouse 30
Not applicableUnknownNCT03454269
What this trial is testing

Role of Retina in Mechanisms of Illusions and Visual Hallucinations Observed in Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's DiseaseVisual Hallucinations
University Hospital, Clermont-Ferrand 90
Next Page